SPONGA F, CAVALETTI L, LAZZARINI A, et al. Biodiversity and potentials of marine-derived microorganisms[J]. Journal of Biotechnology, 1999, 70(1-3): 65-69.
[2]
DREYFUSS M， MCHAPELA I H. Potential of fungi in the discovery of novel, low-molecular weight pharmaceuticals[J]. Biotechnology, 1994, 26: 49-80.
[3]
林爱群. 三株海洋真菌次级代谢产物活性成分的研究[D]. 山东青岛： 中国海洋大学， 2008.
[4]
BROWN A J, GOLDSWORTHY S M, BARNES A A, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids[J]. J Biol Chem, 2003, 278(13): 11312-11319.
[5]
LIN A, LU X, FANG Y, et al. Two new 5-hydroxy-2-pyrone derivatives isolated from a marine-derived fungus Aspergillus flavus[J]. J Antibiot (Tokyo), 2008, 61(4): 245-249.
[6]
HAVLICKOVA M, PREZEAU L, DUTHEY B, et al. The intracellular loops of the GB2 subunit are crucial for G-protein coupling of the heteromeric gamma-aminobutyrate B receptor[J]. Mol Pharmacol, 2002, 62(2): 343-350.
[7]
UHLENBROCK K, GASSENHUBER H, KOSTENIS E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors[J]. Cell Signal, 2002, 14(11): 941-953.
[8]
GRAZ C J, GRANT G D, BRAUNS S C, et al. Cyclic dipeptides in the induction of maturation for cancer therapy[J]. J Pharm Pharmacol, 2000, 52(1): 75-82.
